SEARCH

SEARCH BY CITATION

References

  • 1
    Anderson, K.C. & Weinstein, H.J. (1990) Transfusion-associated graft-versus-host disease. New England Journal of Medicine, 233, 315 321.
  • 2
    Arcese, W., Mauro, F.R., Alimena, G., Lo Coco, F., De Cuia, M.R., Screnci, M., Iori, A.P., Montefusco, E., Mandelli, F. (1990) Interferon therapy for Ph1 positive CML patients relapsing after T cell-depleted allogeneic bone marrow transplantation. Bone Marrow Transplantation, 5, 309 315.
  • 3
    Barrett, A.J., Locatelli, F., Treleaven, J.G., Gratwohl, A., Szydlo, R., Zwaan, F.E. (1991) Second transplants for leukaemic relapse after bone marrow transplantation: high early mortality but favourable effect of chronic GVHD on continued remission. A report by the EBMT Leukaemia Working Party. British Journal of Haematology, 79, 567 574.
  • 4
    Barrett, A.J. & Malkovska, V. (1996) Graft-versus-leukaemia: understanding and using the alloimmune response to treat haematological malignancies. British Journal of Haematology, 93, 754 761.
  • 5
    Barrett, A.J., Mavroudis, D., Molldrem, J., Read, E.J., Carter, C., Dunbar, C., Young, N.S. (1996) Optimizing the dose and timing of lymphocytes add-back in T-cell-depleted BMT between HLA-identical siblings. Blood, 88, (Suppl. 1), 460a.
  • 6
    Bonini, C., Ferrari, G., Verzelletti, S., Servida, P., Zappone, E., Ruggieri, L., Ponzoni, M., Rossini, S., Mavilio, F., Traversari, C., Bordignon, C. (1997) HSV-TK gene transfer into donor-lymphocytes for control of allogeneic graft-versus-leukemia. Science, 276, 1719 1724.
  • 7
    Bosi, A., Bacci, S., Miniero, R., Locatelli, F., Laszlo, D., Longo, G., Busca, A., van Lint, M.T., Di Bartolomeo, P., Amici, A. (1997) Second allogeneic bone marrow transplantation in acute leukemia: a multicenter study from the Gruppo Italiano Trapianto di Midollo Osseo. Leukemia, 11, 420 424.
  • 8
    Cardoso, A.A., Schultze, J.L., Boussiotis, V.A., Freeman, G.J., Seamon, M.J., Laszlo, S., Billet, A., Sallan, S.E., Gribben, J.G., Nadler, L.M. (1996) Pre-B acute lymphoblastic leukemia cells may induce T-cell anergy to alloantigen. Blood, 88, 41 48.
  • 9
    Cardoso, A.A., Seamon, M.J., Afonso, H.M., Ghia, P., Boussiotis, V.A., Freeman, G.J., Gribben, J.G., Sallan, S.E., Nadler, L.M. (1997) Ex vivo generation of human anti-pre-B leukemia-specific autologous cytolytic T cells. Blood, 90, 549 561.
  • 10
    Collins, R.H., J., Shpilberg, O., Drobyski, W.R., Porter, D.L., Giralt, S., Champlin, R., Goodman, S.A., Wolff, S.N., Hu, W., Verfaillie, C., List, A., Dalton, W., Ognoskie, N., Chetrit, A., Antin, J.H., Nemunaitis, J. (1997) Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. Journal of Clinical Oncology, 15, 433 444.
  • 11
    Comoli, P., Montagna, D., Moretta, A., Zecca, M., Locatelli, F., Maccario, R. (1995) Alloantigen-induced human lymphocytes rendered nonresponsive by a combination of anti-CD80 monoclonal antibodies and cyclosporin-A suppress mixed lymphocyte reaction in vitro. Journal of Immunology, 155, 5506 5511.
  • 12
    Cullis, J.O., Schwarer, A.P., Hughes, T.P., Hows, J.M., Franklin, I., Morgenstern, G., Goldman, J.M. (1992) Second transplants for patients with chronic myeloid leukaemia in relapse after original transplant with T-depleted donor marrow: feasibility of using busulphan alone for re-conditioning. British Journal of Haematology, 80, 33 39.
  • 13
    Dazzi, F., Raanani, P., van Rhee, P., Szydlo, R., Olavarria, E., Kaeda, J., Apperley, J.F., Cross, N.C.P., Goldman, J.M. (1998) Donor lymphocyte infusion (DLI) for relapse of CML after allo-BMT: comparison of two regimens. Bone Marrow Transplantation, 21, (Suppl. 1), S70.
  • 14
    Faber, L.M., van-Luxemburg Heijs, S.A., Willemze, R., Falkenburg, J.H. (1992) Generation of leukemia-reactive cytotoxic T lymphocyte clones from the HLA-identical bone marrow donor of a patient with leukemia. Journal of Experimental Medicine, 176, 1283 1289.
  • 15
    Falkenburg, J.H., Smit, W.M., Willemze, R. (1997a) Cytotoxic T-lymphocyte (CTL) responses against acute or chronic myeloid leukemia. Immunological Reviews, 157, 223 230.
  • 16
    Falkenburg, J.H., Wafelman, A.R., van Bergen, C.A.M., Bongaerts, R., Lurvink, E.G.A., Posthuma, E.F.M., Smit, W.M., Joosten, P., Landegent, J.E., Kluin-Nelemans, J.C., Fibbe, W.E., Willemze, R. (1997b) Leukemia-reactive cytotoxic T lymphocytes (CTL) induce complete remission in a patient with refractory accelerated phase chronic myeloid leukemia (CML). Blood, 90, (Suppl. 1), 589a.
  • 17
    Frassoni, F., Barrett, A.J., Granena, A., Ernst, P., Garthon, G., Kolb, H.J., Prentice, H.G., Vernant, J.P., Zwaan, F.E., Gratwohl, A. (1988) Relapse after allogeneic bone marrow transplantation for acute leukaemia: a survey of the EBMT of 117 cases. British Journal of Haematology, 70, 317 320.
  • 18
    Giralt, S., Hester, J., Huh, Y., Hirsch Ginsberg, C., Rondon, G., Seong, D., Lee, M., Gajewski, J., Van Besien, K., Khouri, I., Mehra, R., Przepiorka, D., Korbling, M., Talpaz, M., Kantarjian, H., Fischer, H., Deisseroth, A., Champlin, R. (1995) CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation. Blood, 86, 4337 4343.
  • 19
    Gluckman, E., Rocha, V., Boyer-Chammard, A., Locatelli, F., Arcese, W., Pasquini, R., Ortega, J., Souillet, G., Ferreira, E., Laporte, J.P., Fernandez, M., Chastang, C. (1997) Outcome of cord blood transplantation from related and unrelated donors. New England Journal of Medicine, 337, 373 381.
  • 20
    Goulmy, E. (1997) Human minor histocompatibility antigens: new concepts for marrow transplantation and adoptive immunotherapy. Immunological Reviews, 157, 125 140.
  • 21
    Guinan, E.C., Gribben, J.G., Boussiotis, V.A., Freeman, G.J., Nadler, L.M. (1994) Pivotal role of the B7: CD28 pathway in transplantation tolerance and tumor immunity. Blood, 84, 3261 3282.
  • 22
    Horowitz, M.M., Gale, R.P., Sondel, P.M., Goldman, J.M., Kersey, J., Kolb, H.J., Rimm, A.A., Ringden, O., Rozman, C., Speck, B., Truitt, R.L., Zwaan, F.E., Bortin, M.M. (1990) Graft-versus-leukemia reactions after bone marrow transplantation. Blood, 75, 555 562.
  • 23
    Johnson, B.D., Drobyski, W.R., Truitt, L.R. (1993) Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemic reaction without graft-versus-host disease. Bone Marrow Transplantation, 11, 329 336.
  • 24
    Kolb, H.J., Mittermuller, J., Clemm, C., Holler, E., Ledderose, G., Brehm, G., Heim, M., Wilmanns, W. (1990) Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood, 76, 2462 2465.
  • 25
    Kolb, H.J., Schattenberg, A., Goldman, J.M., Hertenstein, B., Jacobsen, N., Arcese, W., Ljungman, P., Ferrant, A., Verdonck, L., Niederwieser, D., van Rhee, F., Mittermuller, J., De Witte, T., Holler, E., Ansari, H. (1995) Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party in Chronic Leukemia. Blood, 86, 2041 2050.
  • 26
    Kwak, L.W., Taub, D.D., Duffey, P.L., Besinger, W.I., Bryant, E.M., Reynolds, C.W., Longo, D.L. (1995) Transfer of myeloma idiotype-specific immunity from an actively immunised marrow donor. Lancet, 345, 1016 1020.
  • 27
    Lin, F., Dazzi, F., Sohal, J., Szydlo, R.M., van Rhee, R., Reiter, A., Goldman, J., Cross, N.C. (1997) The rate and kinetics of molecular response to donor leukocyte transfusions in chronic myeloid leukaemia patients treated for relapse after allogeneic bone marrow transplantation. British Journal of Haematology, 99, 945 950.
  • 28
    Locatelli, F., Comoli, P., Giorgiani, G., Carrà, A.M., Di Giulio, G., Di Maggio, E.M., Pellegrini, N., Maccario, R. (1997) Infusion of donor-derived peripheral blood leukocytes after transplantation of cord blood progenitor cells can increase the graft-versus-leukemia effect. Leukemia, 11, 729 731.
  • 29
    Lokhorst, H.M., Schattenberg, A., Cornelissen, J.J., Thomas, L.L.M., Verdonck, L.F. (1997) Donor leukocyte infusion are effective in relapsed multiple myeloma after allogeneic bone marrow transplantation. Blood, 90, 4206 4211.
  • 30
    Mackinnon, S., Papadopoulos, E.B., Carabasi, M.H., Reich, L., Collins, N.H., Boulad, F., Castro Malaspina, H., Childs, B.H., Gillio, A.P., Kernan, N.A., Small, T.N., Young, J.W., O'reilly, R.J. (1995) Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease. Blood, 86, 1261 1268.
  • 31
    Mehta, J., Powles, R., Treleaven, J., Horton, C., Meller, S., Pinkerton, C.R., Singhal, S. (1997) Outcome of acute leukemia relapsing after bone marrow transplantation: utility of second transplants and adoptive immunotherapy. Bone Marrow Transplantation, 19, 709 719.
  • 32
    Molldrem, J., Dermime, S., Parker, K., Jiang, Y.Z., Mavroudis, D., Hensel, N., Fukushima, P., Barrett, A.J. (1996) Targeted T-cell therapy for human leukemia: cytotoxic T lymphocytes specific for a peptide derived from proteinase 3 preferentially lyse human myeloid leukemia cells. Blood, 88, 2450 2457.
  • 33
    Mrsic, M., Horowitz, M.M., Atkinson, K., Biggs, J.C., Champlin, R.E., Ehninger, G., Gajewski, J.L., Gale, R.P., Herzig, R.H., Prentice, H.G., Rozman, C., Sobocinski, K.A., Speck, B., Bortin, M.M. (1992) Second HLA-identical sibling transplants for leukemia recurrence. Bone Marrow Transplantation, 9, 269 275.
  • 34
    Murphy, W.J. & Longo, D.L. (1997) The potential role of NK cells in the separation of graft-versus-tumor effects from graft-versus-host disease after allogeneic bone marrow transplantation. Immunological Reviews, 157, 167 176.
  • 35
    Porter, D.L., Roth, M.S., McGarigle, C., Ferrara, J.L., Antin, J.H. (1994) Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia. New England Journal of Medicine, 330, 100 106.
  • 36
    Raanani, P., Dazzi, F., Sohal, J., Szydlo, R., van Rhee, F., Reiter, A., Lin, F., Goldman, J.M., Cross, C.P. (1997) The rate and kinetics of molecular response to donor leucocyte transfusions in chronic myeloid leukaemia patients treated for relapse after allogeneic bone marrow transplantation. British Journal of Haematology, 99, 945 950.
  • 37
    Radich, J.P., Sanders, J.E., Buckner, C.D., Martin, P.J., Petersen, F.B., Bensinger, W., McDonald, G.B., Mori, M., Schoch, G., Hansen, J.A. (1993) Second allogeneic marrow transplantation for patients with recurrent leukemia after initial transplant with total-body irradiation-containing regimens. Journal of Clinical Oncology, 11, 304 313.
  • 38
    Sanders, J.E., Buckner, C.D., Clift, R.A., Fefer, A., McGuffin, R., Storb, R., Appelbaum, F., Bensinger, W., Beatty, P., Doney, K. (1988) Second marrow transplants in patients with leukemia who relapse after allogeneic marrow transplantation. Bone Marrow Transplantation, 3, 11 19.
  • 39
    Slavin, S., Ackerstein, A., Naparstek, E., Or, R., Weiss, L. (1990) The graft-versus-leukemia (GVL) phenomenon: is GVL separable from GVHD? Bone Marrow Transplantation, 6, 155 161.
  • 40
    Slavin, S., Naparstek, E., Nagler, A., Ackerstein, A., Samuel, S., Kapelushnik, J., Brautbar, C., Or, R. (1996) Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukaemia relapse after allogeneic bone marrow transplantation. Blood, 87, 2195 2204.
  • 41
    Truitt, R.L. & Atasoylu, A.A. (1991) Impact of pretransplant conditioning and donor T cells on chimerism, graft-versus-host disease, graft-versus-leukemia reactivity, and tolerance after bone marrow transplantation. Blood, 77, 2515 2523.
  • 42
    van Rhee, F., Lin, F., Cullis, J.O., Spencer, A., Cross, N.C., Chase, A., Garicochea, B., Bungey, J., Barrett, J., Goldman, J.M. (1994) Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: the case for giving donor leukocyte transfusions before the onset of hematologic relapse. Blood, 83, 3377 3383.
  • 43
    Verdonck, L.F., Lokhorst, H.M., Dekker, A.W., Nieuwenhuis, H.K., Petersen, E.J. (1996) Graft-versus-myeloma effect in two cases. Lancet, 347, 800 801.